98%
921
2 minutes
20
Correction for 'Fucoidans from ameliorate renal interstitial fibrosis inhibition of the PI3K/Akt/NF-κB signaling pathway' by Zhuoyue Song , , 2022, , 1168-1179, DOI: 10.1039/D1FO03067A.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/d2fo90016e | DOI Listing |
Nan Fang Yi Ke Da Xue Xue Bao
August 2025
First Affiliated Hospital of Anhui University of Chinese Medicine.
Objectives: To investigate the mechanism of (QJZ) for ameliorating renal damage in MRL/lpr mice.
Methods: With 6 female C57BL/6 mice as the normal control group, 30 female MRL/lpr mice were randomized into model group, QJZ treatment groups at low, moderate and high doses, and prednisone treatment group (6). After 8 weeks of treatment, the mice were examined for 24-h urine protein, creatinine and albumin levels, serum levels of IgG, complement 3 (C3), C4, anti-dsDNA, interferon γ (IFN‑γ) and interleukin 17 (IL-17).
Phytomedicine
August 2025
School of Chinese Materia Medica, Beijing University of Chinese Medicine, 102488, China. Electronic address:
Background: Diabetic nephropathy (DN), a serious diabetic complication, currently has limited treatment options. Yulan Jiangtang capsules (YL) are a clinically approved traditional Chinese medicine formula for glycemic control and diabetes-related complications. Nevertheless, the underlying mechanisms of their therapeutic effects remain incompletely elucidated.
View Article and Find Full Text PDFCurr Med Sci
September 2025
Shanghai Medical College of Fudan University, Shanghai, 200032, China.
Objective: Traditional Chinese medicine exhibits positive therapeutic effects as a primary or adjunctive treatment for diabetic nephropathy (DN). This study aimed to evaluate the impact and mechanism of action of Xiaoke decoction (XKD), a traditional Chinese medicine, on renal function in DN rats.
Methods: A rat model of DN was established, and the rats were divided into five groups (n = 7 per group): normal control group (NC), DN model group (DN), low-dose XKD treatment group (DN + XKD-L, 1.
Horm Metab Res
September 2025
technology, Beautech stem cell hospital, Qionghai, China.
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease involving multiple organs. It affects the quality of life of patients significantly. Traditional treatments have certain limitations, such as side effects caused by long-term intake, complications owing to prolonged pathogenesis, and limited therapeutic effects.
View Article and Find Full Text PDFPhytomedicine
August 2025
State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, China. Electronic address:
Background: Diabetic kidney disease (DKD) represents a common microvascular complication associated with diabetes. Research suggests that lipid accumulation contributes to lipotoxicity, exacerbating kidney injury in DKD. Quercetin (QCT), a flavonoid derived from specific fruits and vegetables, has shown potential in mitigating DKD progression; however, its precise protective mechanisms remain to be explored.
View Article and Find Full Text PDF